FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

Showing live article 443 of 678 in channel 53195985
Article Details:

Author:
Language: English
Channel Number: 53195985
Article Number: 443
Date: December 24, 2017, 5:18 am
URL: https://newdrugapprovals.org/2017/12/24/fda-updates-the-label-of-tasigna-to-reflect-that-certain-patients-with-a-type-of-leukemia-may-be-eligible-to-stop-treatment-after-sustained-response/
GUID: http://newdrugapprovals.org/2017/12/24/fda-updates-the-label-of-tasigna-to-reflect-that-certain-patients-with-a-type-of-leukemia-may-be-eligible-to-stop-treatment-after-sustained-response/